CE Koro, SJ Bowlin, N Bourgeois, DO Fedder - Diabetes Care, 2004 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—The study population was derived from NHANES III
(n = 1,215) and NHANES 1999–2000 (n = 372) subjects who reported a diagnosis
of type 2 diabetes with available data on diabetes medication and HbA 1c . ... Cited by 395 - Related articles - BL Direct - All 7 versions
M Korytkowski - International journal of obesity and related metabolic …, 2002 - ncbi.nlm.nih.gov Insulin therapy has proven benefits in Type 2 diabetes patients when combination
therapy has failed. However, there is some reluctance by both patients and
healthcare professionals to initiate insulin therapy. This reluctance has ... Cited by 203 - Related articles - BL Direct - All 4 versions
SH Saydah, J Fradkin, CC Cowie - Jama, 2004 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Control of blood ... Cited by 779 - Related articles - BL Direct - All 8 versions
MC Riddle - Diabetes/Metabolism Reviews - interscience.wiley.com At least 8% of the combined population of the United States (US) and Canada have
diabetes, and in about one-third of these people, the disease is undiagnosed[1].
Diabetes is not evenly distributed geographically, and there is ... Cited by 74 - Related articles - BL Direct - All 4 versions
MC Riddle, J Rosenstock, J Gerich - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In a randomized, open-label, parallel, 24-week
multicenter trial, 756 overweight men and women with inadequate glycemic control
(HbA 1c >7.5%) on one or two oral agents continued prestudy oral agents and ... Cited by 424 - Related articles - BL Direct - All 6 versions
WH Polonsky, L Fisher, S Guzman, L Villa- … - Diabetes Care, 2005 - Am Diabetes Assoc To achieve tight glycemic control in type 2 diabetic patients, it may be
advantageous to introduce insulin therapy much earlier in the disease course
(1). Unfortunately, many patients are reluctant to begin insulin and may ... Cited by 100 - Related articles - BL Direct - All 6 versions
- Free from Publisher A Wright, AC Burden, RB Paisey, CA CULI, … - Diabetes Care, 2002 - cat.inist.fr OBJECTIVE- To evaluate the efficacy of the addition of insulin when maximal
sulfonylurea therapy is inadequate in individuals with type 2 diabetes. RESEARCH
DESIGN AND METHODS- Glycemic control, hypoglycemia, and body weight were ... Cited by 222 - Related articles - BL Direct - All 5 versions
LM Hunt, MA Valenzuela, JA Pugh - Diabetes Care, 1997 - Am Diabetes Assoc OBJECTIVE: This study examines NIDDM patients' attitudes toward insulin
injections, the basis of these attitudes, and how they may affect patients'
willingness to take insulin. RESEARCH DESIGN AND METHODS: Forty-four ... Cited by 173 - Related articles - BL Direct - All 6 versions
P Raskin, E Allen, P Hollander, A Lewin, RA … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—A total of 209 subjects completed the study. At study end, the mean
HbA 1c value was lower in the BIAsp 70/30 group than in the glargine group (6.91
± 1.17 vs. 7.41 ± 1.24%, P < 0.01). The HbA 1c reduction was greater in ... Cited by 323 - Related articles - All 7 versions
[CITATION] Insulin Glargine 4002 Study Investigators. The treat-to-target trial: randomized addition of …
